loading

なぜRevolution Medicines Inc(RVMD)の株価が下がっていますか?

2025-05-27 の取引セッション中に、Revolution Medicines Inc (RVMD) 株の 7.03% 下落を確認しました。これは通常のボラティリティやさまざまな内部および外部要因に起因する可能性がありますが、当社では状況を積極的に監視しており、できるだけ早くタイムリーな最新情報を提供することに注意してください。
2023-10-23:

Shares of Revolution Medicines (RVMD) dropped by 34.38% from $27.97 to $18.36 in the trading on Monday, October 23, 2023. The reason why RVMD stock down is due to the release of data from their RMC-6236 phase 1 study targeting NSCLC and PDAC treatment at the ESMO Congress in Madrid. Expectations were high, with RVMD's stock having risen over 40% year-to-date just the previous week. However, RMC-6236's performance disappointed, with an objective response rate of only 30% in NSCLC after unconfirmed responses were excluded. In PDAC, only 19.6% of patients achieved a partial response, with four of them being unconfirmed. RVMD's CEO expressed confidence in RMC-6236, but analyst Jonathan Chang noted that the results may have fallen short of investor expectations.

$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
大文字化:     |  ボリューム (24 時間):